Protalix BioTherapeutics (PLX) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 18.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.24% |
| Dec 31, 2025 | -45.06% |
| Sep 30, 2025 | -33.71% |
| Jun 30, 2025 | 39.28% |
| Mar 31, 2025 | 76.30% |
| Dec 31, 2024 | -31.47% |
| Sep 30, 2024 | 45.04% |
| Jun 30, 2024 | -31.42% |
| Mar 31, 2024 | 30.93% |
| Dec 31, 2023 | -11.51% |
| Sep 30, 2023 | -73.27% |
| Jun 30, 2023 | 53.56% |
| Mar 31, 2023 | 86.13% |
| Dec 31, 2022 | 55.42% |
| Sep 30, 2022 | 21.56% |
| Jun 30, 2022 | -9.95% |
| Mar 31, 2022 | -42.41% |
| Dec 31, 2021 | 109.69% |
| Sep 30, 2021 | -55.13% |
| Jun 30, 2021 | 55.21% |
| Mar 31, 2021 | 29.34% |
| Dec 31, 2020 | -35.72% |
| Sep 30, 2020 | 108.43% |
| Jun 30, 2020 | 11.29% |
| Mar 31, 2020 | 38.67% |
| Dec 31, 2019 | -32.04% |
| Sep 30, 2019 | -1.62% |
| Jun 30, 2019 | 24.87% |
| Mar 31, 2019 | 7.18% |
| Dec 31, 2018 | -27.98% |
| Sep 30, 2018 | 49.35% |
| Jun 30, 2018 | -20.65% |
| Mar 31, 2018 | -15.84% |
| Mar 31, 2017 | -21.47% |
| Dec 31, 2016 | 97.34% |
| Sep 30, 2016 | -27.24% |
| Jun 30, 2016 | -12.02% |
| Mar 31, 2016 | 2.37% |
| Dec 31, 2015 | 195.30% |
| Sep 30, 2015 | -3.88% |
| Jun 30, 2015 | -32.60% |
| Mar 31, 2015 | -32.76% |
| Mar 31, 2014 | -37.63% |
| Dec 31, 2013 | 29.66% |
| Sep 30, 2013 | 94.28% |